Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$2.84 - $5.0 $105 - $185
-37 Reduced 14.07%
226 $1,000
Q1 2022

May 16, 2022

SELL
$3.74 - $6.63 $355 - $629
-95 Reduced 26.54%
263 $1,000
Q4 2021

Feb 14, 2022

SELL
$5.48 - $9.86 $383 - $690
-70 Reduced 16.36%
358 $2,000
Q1 2021

May 17, 2021

SELL
$15.31 - $26.52 $24,067 - $41,689
-1,572 Reduced 78.6%
428 $7,000
Q4 2020

Feb 16, 2021

BUY
$16.84 - $27.59 $33,680 - $55,180
2,000 New
2,000 $53,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $59.3M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.